BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20230759)

  • 21. Development of novel agents based on nitric oxide for the control of colon cancer.
    Kozoni V; Rosenberg T; Rigas B
    Acta Pharmacol Sin; 2007 Sep; 28(9):1429-33. PubMed ID: 17723176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
    Mahmud SM; Tanguay S; Bégin LR; Franco EL; Aprikian AG
    Eur J Cancer Prev; 2006 Apr; 15(2):158-64. PubMed ID: 16523013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprevention of colorectal cancer.
    Gwyn K; Sinicrope FA
    Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
    Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
    Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
    Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P; Zhao X; Allen J; Li F; Chang M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of COX inhibitors in cancer prevention and therapy.
    Umar A; Viner JL; Anderson WF; Hawk ET
    Am J Clin Oncol; 2003 Aug; 26(4):S48-57. PubMed ID: 12902856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.
    Rigas B
    Curr Opin Gastroenterol; 2007 Jan; 23(1):55-9. PubMed ID: 17133086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
    Harris RE
    Inflammopharmacology; 2009 Apr; 17(2):55-67. PubMed ID: 19340409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S; Bamba H; Kato A
    Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs celecoxib and nimesulide inhibit androgen receptor activity via induction of c-Jun in prostate cancer cells.
    Pan Y; Zhang JS; Gazi MH; Young CY
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):769-74. PubMed ID: 12917209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
    Pereg D; Lishner M
    J Intern Med; 2005 Aug; 258(2):115-23. PubMed ID: 16018788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
    Vainio H; Morgan G
    Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer chemoprevention: difficulties, promise and potential agents?
    Dragnev K; You M; Wang Y; Lubet R
    Expert Opin Investig Drugs; 2013 Jan; 22(1):35-47. PubMed ID: 23167766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Inflammatory Drugs as Anticancer Agents.
    Zappavigna S; Cossu AM; Grimaldi A; Bocchetti M; Ferraro GA; Nicoletti GF; Filosa R; Caraglia M
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.